News & Views
Heart drug could treat respiratory failure
Sep 23 2011
According to findings published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine, the calcium-sensitising drug levosimendan could be effective in improving muscle function in patients with respiratory muscle weakness.
Dr Leo Heunks, a pulmonary and critical care physician at Radboud University Nijmegen Medical Centre in the Netherlands, explained that levosimendan improved the efficiency of the diaphragm, which suggests it may improve muscle function in those with respiratory failure.
The drugs are effective because muscles need calcium in order to contract and calcium sensitisers improve the muscles' ability to contract.
"Respiratory muscle weakness frequently occurs in patients with chronic diseases, and also in critically ill patients on the ventilator, making breathing more difficult and causing more severe illness and even death," Dr Heunks explained.
"To date, there is no specific drug treatment available to improve respiratory muscle function in patients with respiratory muscle failure."
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK
May 21 2024 Lagos, Nigeria